| Sources | Names Used |
|---|---|
| CCLE, GDSC1000, FIMM | Nilotinib |
| CTRPv2 | nilotinib |
| PharmacoGx | Nilotinib |
| Database | Identifier |
|---|---|
| Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
| Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
| Pubchem: | 644241 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CFAP161 | GDSC1000 | pan-cancer | AAC | 0.52 | 1e-55 |
| mRNA | PIM1 | CTRPv2 | pan-cancer | AAC | 0.52 | 5e-49 |
| mRNA | CISH | CTRPv2 | pan-cancer | AAC | 0.49 | 1e-43 |
| mRNA | PRSS57 | GDSC1000 | pan-cancer | AAC | 0.5 | 3e-42 |
| mRNA | APOL4 | CCLE | pan-cancer | AAC | 0.62 | 5e-41 |
| mRNA | APOL4 | GDSC1000 | pan-cancer | AAC | 0.47 | 2e-40 |
| mRNA | OSM | GDSC1000 | pan-cancer | AAC | 0.5 | 9e-40 |
| mRNA | CISH | GDSC1000 | pan-cancer | AAC | 0.48 | 3e-38 |
| mRNA | KLF1 | GDSC1000 | pan-cancer | AAC | 0.42 | 2e-34 |
| mRNA | RHD | GDSC1000 | pan-cancer | AAC | 0.39 | 8e-30 |
